PharmaCyte Biotech Overview

PharmaCyte Biotech Other Income Expense Net

Other Income/Expense Net for PMCB.

Quarterly Other Income/Expense

$2.86M

↑ 237.4% YoY

As of Jan 31, 2026

Annual Other Income/Expense (TTM)

$1.10M

↓ 94.96% YoY

Trailing 12 months ending Jan 31, 2026

Average Other Income/Expense (Comparison Companies)

Other Income Expense Net History

Other Income Expense Net Comparison

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin